Background {#Sec1}
==========

Asthma is the most common chronic respiratory disease affecting up to 18% of the people in the world \[[@CR1]\]. An estimated 334 million people suffer from asthma \[[@CR2]\], and the disease is uncontrolled for many patients in developing and undeveloped countries. For example, in Asia, asthma was controlled in only 2.5% of the affected population in 2006 \[[@CR3]\], burdening patients, families, governments, and healthcare systems \[[@CR4]\]. To prevent the processes of asthma, a myriad of effective measures have been identified and international guidelines concerning asthma self-management education have been promulgated, that have had a positive effect on outcomes \[[@CR5]\].

Asthma causes long-term inflammation in the lungs that requires patients to modify their lifestyles---such as smoking cessation and the avoidance of passive smoke. Therefore, healthcare providers at the point of care should be skilled and experienced in asthma self-management education and behavior change strategies to improve the quality-of-life of asthma sufferers \[[@CR6]\]. Germane to asthma self-management education, numerous randomized controlled trials have demonstrated positive changes in patient-centered outcomes related to education and behavioral interventions \[[@CR7]\]. Nevertheless, many healthcare providers lack training in self-management education and many have little time or motivation to help patients develop those skills \[[@CR8]\].

As the use of mobile devices and smartphones becomes more ubiquitous, patients could make full use of applications (apps) on these devices for asthma self-management \[[@CR8]\]. Currently, apps on mobile devices can enable patients to monitor and manage the disease, obtain education, and improve health behavior. Communication among users or with practitioners can become more frequent with mHealth apps and mobile technology \[[@CR9]\]. Therefore, healthcare providers should assist asthmatics in identifying mHealth smartphone apps that help manage the disease and enable them to provide detailed and personalized feedback to patients at any time \[[@CR10]\]. For example, the China Internet Network Information Center (CNNIC) released its annual report on the development of the Internet in China in June 2017, indicating China had 751 million Internet users and 724 million mobile Internet users, an increase of 28.3 million from 2016 \[[@CR11]\]. Two hundred fifty-nine thousand mHealth apps were available on major app stores worldwide \[[@CR12]\]. These apps have the potential to help a variety of patients improve self-management of their long-term, chronic conditions \[[@CR13]\].

Although mHealth apps hold promise and provide advantages for improving health, their quality and suitability for use in clinical practice must be evaluated. Currently, user-based rating systems are provided by the Apple App Store and Google Play (previously Android Market). These rating systems allow users to rank apps from one to five stars in terms of criteria such as usability; however, the validity and reliability of these rating systems and ratings have yet to be reported \[[@CR14]\]. As long as the mHealth apps available on these platforms do not make misleading advertising claims and protects the data and identities of the users, they can provide benefit to potential users with chronic diseases \[[@CR15]\]. Nevertheless, mHealth apps have rarely adhered to evidence-based principles and peer-reviewed guidelines \[[@CR16]\]. For example, Rosser and Eccleston reviewed apps for pain management and report that 86% of the apps indicated no involvement of medical professionals \[[@CR17]\]. Moreover, the health information delivered on mHealth apps frequently lacks scientific basis and validity \[[@CR18]\]. Furthermore, malfunctions, breaches of patient confidentiality, and conflicts of interests involving apps all conspire against the provision of safe patient care \[[@CR19]\]. The staggering number and variety of these mHealth apps makes it difficult for clinicians and the public to identify which of the apps are the safest and most effective \[[@CR20], [@CR21]\]. In addition, a lack of standardized rating tools further limits the potential use of apps as part of legitimate healthy lifestyle interventions. Although several assessment frameworks have been published to help rate app quality (e.g., Huckvale et al. developed criteria to assess the content quality of asthma apps \[[@CR22]\], and Tinschert et al. applied review frameworks \[i.e., behavior change techniques and information\] to investigate the potential of asthma apps for self-management \[[@CR23]\]), no single instrument addresses the unique combination of information and behavior strategies necessary for asthma patients to effectively self-manage their care.

Clearly, an objective and reliable instrument is necessary to rate the quality of mHealth apps---especially those related to asthma. This instrument initially could be used by researchers and later be made available to app developers and health professionals. This study aimed to develop a reliable and multidimensional index system for rating the mHealth apps for asthma patients that would satisfy the following criteria: (1) provides evidence for patients with asthma and healthcare providers for choosing apps to treat asthma; (2) presents a reference for developers to design asthma apps systematically and scientifically; (3) contributes to improving quality evaluation standards for apps targeting chronic and common diseases.

Methods {#Sec2}
=======

Study design {#Sec3}
------------

To develop a reliable and multidimensional assessment framework for rating the mHealth apps for asthma patients, a three round Delphi survey was conducted using paper-based forms. Experts were asked to indicate the importance of each item based on a 5-point Likert scale from 1 (i.e., *not important*) to 5 (i.e., *extremely important*) \[[@CR24]\]. Experts provided feedback between each round of the survey and results were summarized. In a Delphi survey, the multi-round iterative process generally continues until the experts arrive at a common understanding of the qualitative data \[[@CR25]\].

No standard methods are available to determine consensus levels \[[@CR26]\]. In this study, consensus between participants was measured using the mean importance rating, the coefficient of variation (CV is the ratio of the standard deviation of the responses of the experts on a specific item to its corresponding mean average), and the percentage important (defined as the percentage of respondents who rated a particular item as *extremely important)* \[[@CR27]\]. Items were either retained, removed, modified, or added in each Delphi round, based on this standard to reach consensus. The criterion of the mean importance rating and the percentage important is the mean of all items minus their standard deviation, and an item whose score greater than or equal to the criterion is preserved. The criterion of the coefficient of variation is all items' mean plus standard deviation, keeping the items whose score below or equal to the criterion. When item failed to meet either of the above criteria, were deleted. When the item meets one or two criteria, the decision was made after the discussion of a research group consisting of one associate professor, one university lecturer and three master degree students. Data analysis was performed by two of the authors.

After two rounds of the Delphi survey, the relative importance of each item (e.g., *Asthma is a chronic respiratory disease, together with airway hyperresponsiveness and airway inflammation,* and *Asthma cannot be cured, but can be effectively controlled through effective management*) was calculated. The analytic hierarchy process (AHP) fundamental scale developed by Saaty for pairwise comparisons was then used to construct the judgment matrix to calculate the weight of each item \[[@CR28]\].

In the study, each participant compared all criteria pairwise with each other using a scale ranging from 1 to 9 to 1. For each pair, participants had to select which was more important, see Fig. [1](#Fig1){ref-type="fig"}. After collecting the questionnaires, the AHP module matrix written with Excel was utilized for data analysis. Fig. 1A sample question of pairwise comparisons in the questionnaire. 1: Equal importance; 3: Moderate importance of one over another; 5: Essential or strong importance; 7: Very strong importance; 9: Extreme importance; 2, 4, 6, 8: Intermediate values between the two adjacent judgements

In addition, a consistency test was conducted of the judgment matrix. When the random consistency ratio (CR) was less than 0.1, then the judgment matrices were considered acceptable.

The CR coefficient is calculated as follows \[[@CR29]\].

CI represents the consistency index, and RCI represents random consistency index, which was used to modify the CI value (if n \> 2). n means the order of the matrix. $$\documentclass[12pt]{minimal}
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λ~max~ means an approximation of the maximum eigenvalue of the judgement matrix.

The CR coefficient is obtained by dividing the CI value by RCI. The value of RCI of the reciprocal matrix of 1--9 orders is given in Table [1](#Tab1){ref-type="table"}. $$\documentclass[12pt]{minimal}
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Participant recruitment {#Sec4}
-----------------------

Participants were active in the field of respiratory disease having expertise in asthma management. Experts were identified from Beijing and Tianjin working in general hospital or medical university. Experts were identified according to the following criteria: (1) they had to be engaged in the field of respiratory for more than 5 years; (2) they had to hold intermediate professional titles and a college degree or graduate degree in a respiratory field; (3) they had to be willing take part in all rounds of the Delphi survey.

Procedure {#Sec5}
---------

### Developing the initial index system {#Sec6}

The asthma self-management education and behavior change techniques (BCT) and corresponding items to be evaluated through the Delphi survey were identified through (1) a content analysis of 110 asthma apps from the Apple App Store and Google Play that covered self-management education and functions \[[@CR30]\] and (2) a review of the relevant literature.

For the literature review, major databases (i.e., PubMed, Ovid, EBSCO, Elsevier, SpringerLink, SinoMed, China National Knowledge Infrastructure \[CNKI\], and WanFang) were searched using the keywords *asthma* and *self-management* or *behavior change techniques* or *mobile app\** and *evaluate\** or *mobile app\** and *assess\** between the date January 2013 and October 2017. There were 10,545 articles retrieved, 6363 were removed as duplicates, and after initial screening of title and abstract, only 734 articles that reported asthma self-management education, behavior change techniques and evaluation instrument of apps were included. After reading their full text, 14 major relevant articles were identified.

App assessment items were extracted by analyzing the major relevant literature \[[@CR2], [@CR6], [@CR9], [@CR23], [@CR31]--[@CR40]\] by two authors, who then drafted a set of provisional dimensions for the items and sorted them by dimension. A total of 105 items were identified. That fell into 10 major dimensions: (1) goals and planning, (2) feedback and monitoring, (3) shaping knowledge, (4) social support, (5) reward and threat, (6) natural consequences, (7) improving the compliance, (8) asthma information, (9) patient skills training, and (10) non-pharmacological interventions. After removing redundant items, 87 items remained, which the authors then grouped into 23 sub-dimensions, defining the 10 major dimensions. They were (1) goal setting (outcome/behavior), (2) asthma action plans, (3) self-monitoring of behavior, (4) self-monitoring of outcomes of behavior, (5) feedback, (6) demonstration of the behavior, (7) behavior substitution, (8) practical social support, (9) emotional support, (10) social reward, (11) threat, (12) information about health consequences, (13) salience of consequences, (14) prompts. (15) regulation, (16) the nature of asthma, (17) asthma medication, (18) management of asthma exacerbation, (19) management of comorbidities, (20) peak flow meter usage, (21) inhaler technique, (22) identifying and avoiding risk factors, (23) good life style. The research group ensure that the survey questionnaire did not include items that were difficult to understand or repetitive. The preliminary list of proposed items underwent a process of revision and adaptation to reach a definitive version that was approved by all authors. The questionnaire was sent to each expert who agreed to participate in the study and the Delphi process was explained to these participants. The original list appears in Table [2](#Tab2){ref-type="table"}. Table 2The items in the questionnaires of round 1 Delphi surveyDimensions1. Goals and planning2. Feedback and monitoring3. Shaping knowledge4. Social support5. Reward and threat6. Natural consequences7. Improving the compliance8. Asthma information9. Patient skills training10. Non-pharmacological interventionsSub- dimensions1.1 Goal setting (outcome/behavior)1.2 Asthma action plans2.1 Self-monitoring of behavior2.2 Self-monitoring of outcomes of behavior2.3 Feedback3.1 Demonstration of the behavior3.2 Behavior substitution4.1 Practical social support4.2 Emotional support5.1 Social reward5.2 Threat6.1 Information about health consequences6.2 Salience of consequences7.1 Prompts7.2 Regulation8.1 The nature of asthma8.2 Asthma medication8.3 Management of asthma exacerbation8.4 Management of comorbidities9.1 Peak flow meter usage9.2 Inhaler technique10.1 Identifying and avoiding risk factors10.2 Good life styleItems1.1.1 Ask patients to reflect on what they would consider as good asthma control1.1.2 The purpose of asthma control is to have good asthma control and no limited activities1.1.3 Set specific behavior goals in terms of the behavior to be achieved1.1.4 State the factors that influence the behavior, and generate strategies that overcome barriers and increase facilitators1.1.5 Set goals in terms of a positive outcome1.1.6 Re-set new goals in light of achievement1.2.1 Patient should be provided with an asthma action plan, and updated in time1.2.2 State that asthma action plan helps patient to recognize and response appropriately to worsening asthma1.2.3 Set detailed planning of performance of the behavior1.2.4 Patients need to affirm commitment to change the behavior2.1.1 States that the valid approaches for self-monitoring are PEF monitoring and symptom recognition2.1.2 Provides reminders to monitor PEF everyday, and can record details2.1.3 Provides reminders to monitor symptoms everyday, and can record details2.1.4 Provides a diary to record medication2.1.5 Provides a diary to record patients' feeling2.1.5 Provides a diary to record return visit2.2.1 Provides a diary to record lung function test2.2.2 Provides a diary to record worsening asthma-related events2.2.3 Provides a diary to record factors related to worsening asthma, such as weather2.2.4 Provides asthma assessment tools2.3.1 Monitors and provides informative or evaluative feedback on performance of the behavior2.3.2 Provide professional feedback information based on patients' inhaler technique2.3.3 Provides evaluative feedback on asthma status2.3.4 Provides informative feedback on asthma severity based on PEF values2.3.5 Generates PEF/symptoms summary visualization2.3.6 Provides result feedback through connecting medical devices3.1.1 Provide video tutorials or animations of peak flow meter use3.1.2 Provide video tutorials or animations of inhaler devices use3.1.3 Provides video tutorials or animations to display instructions of spacer for patients3.2.1 States wanted or neutral behavior to substitute the unwanted behavior3.2.2 States repetition of the wanted behavior4.1.1 Allows establishing a cooperative relationship between doctors and patients4.1.2 Allows setting goals by patients and doctors4.1.3 Provides video tutorials or animations about asthma information introduced by medical workers4.1.4 Allows users to share health data with medical workers through email4.1.5 Allows patients to communicate with patients with controlled asthma4.2.1 States that friends, relatives and medical workers should provide emotional support4.2.2 Provides encouragement and consultation from friends, relatives and medical workers4.2.3 Provides self-incentive in performing the behavior5.1.1 Send incentive information if there has been progress in performing the behavior5.2.1 Do not send incentive information if patients with unwanted behavior6.1.1 Provides information about health consequences of performing the behavior6.1.2 Provides information about social and environmental consequences of performing the behavior6.2.1 Provides methods specifically designed to emphasize the consequences of performing the behavior7.1.1 Set environmental or social stimulus in order to prompt the behavior7.1.2 Allows users to set reminder for medication/return visit7.1.3 Provides reminders for checking inhaler to ensure inhalers are not empty7.1.4 Provides reminders for checking inhaler to ensure inhalers are in date7.2.1 Provides stress-reduction strategies to prevent symptoms from worsening7.2.2 States the importance of avoiding use of multiple different inhaler types8.1.1 Asthma is a chronic respiratory disease, together with airway hyperresponsiveness and airway inflammation8.1.2 Asthma is caused by a combination of endogenous (genetic) and external (environment) causes.8.1.3 Respiratory symptoms of asthma are wheeze, shortness of breath, chest tightness and cough8.1.4 Asthma severity can be assessed as mild asthma, moderate asthma, and severe asthma8.1.5 Asthma cannot be cured, but can be effectively controlled through effective management.8.1.6 Early controller treatment of asthma is critical to achieving optimal outcomes8.2.1 Asthma medications include controller medications and reliever medications8.2.2 Controller medications can be used to reduce airway inflammation, control symptoms, and reduce future risks8.2.3 Controller medications should be used for regular8.2.4 Reliever medications are used to relief breakthrough symptoms8.2.5 Reliever medications are used as needed8.2.6 Local side-effects of ICS include oral thrush and dysphonia8.2.7 Side-effects of oral corticosteroids include osteoporosis, hypertension, and diabetes, etc.8.2.8 Side-effects of ß~2~-agoinsts include tachycardia and tremor8.2.9 Patients need to carry asthma reliever medications (such as Ventolin solution) with them in case of emergency8.3.1 Early signs and symptoms of worsening asthma are sneezing, runny nose, dry cough, shortness of breath, and chest tightness, etc.8.3.2 Symptoms of asthma exacerbations are a progressive increase in symptoms of shortness of breath, cough, wheezing or chest tightness8.3.3 It is important to adjust treatment plan and went to see the doctor in time8.3.4 Patients were removed from the allergen environment, inhale ß~2~ agonist, and went to see the doctor in time8.4.1 Complications should be treated, such as rhinitis, sinusitis, and symptomatic gastroesophageal reflux disease8.4.2 Obese patient should lose weight9.1.1 Operational criteria of peak expiratory flow meter: taking a deep breath; sealing your mouth tightly around the mouthpiece; blowing as hard and as fast as you soon; checking the number, re-setting the pointer to zero; and repeating two more times9.1.2 A peak flow meter is used for monitoring lung function changes in patients9.1.3 Patients should use the same meter each time9.2.1 Patients should be encouraged to participate in the choice of inhaler device9.2.2 Emphasizes the importance of correct inhaler technique9.2.3 States that patients should breathe deeply and hold their breath for a few seconds for effective use of inhaler devices9.2.4 Patients should rinse and spit the mouse after using the inhaled hormone9.2.5 States that appropriate use of spacer device can improve effect and reduce adverse drug reactions10.1.1 States identifying risk factors that make asthma worse10.1.2 States the importance of avoidance of environmental smoke exposure10.1.3 States the importance of avoidance of occupational exposures10.1.4 States the importance of avoidance of medications that may make asthma worse10.1.5 States the importance of avoidance of allergens exposure10.2.1 States the importance of consuming a diet high in fruit and vegetables10.2.2 States the importance of avoidance of indoor air pollutants10.2.3 States the importance of engaging in regular physical activity

### Round 1 of Delphi survey {#Sec7}

In round one of the Delphi survey, in November, 2017, a total of 25 experts agreed to participate in the Delphi survey. They represented six hospitals and/or academic institutions in Beijing and Tianjin, including Capital Medical University School of Nursing, Beijing Chaoyang Hospital affiliated to Capital Medical University, Xuanwu Hospital affiliated to Capital Medical University, Beijing Children's Hospital affiliated to Capital Medical University, China-Japan Friendship Hospital in Beijing, and Tianjin Medical University General Hospital. All expert participants in round one were female whose ages ranging from 31 to 55 years (mean = 42.28; SD = 6.58). Participants were drawn from three main occupational groups: nurse educators in higher education, clinical head nurses, and respiratory physicians.

The first-round questionnaire contained 10 dimensions, 23 sub-dimensions, and 87 items. In addition, the questionnaire contained of 50 items related to behavioral change strategies and 37 items related to asthma self-management education.

The first section of the first-round questionnaire (1) describes the background and objectives of the study and (2) specifies the deadline for returning the completed questionnaire. The second section elicits the opinions of experts concerning not only the revision, addition, and/or deletion of any items, but also the importance of each item based on a 5-point Likert scale. In addition, participants were given an option to suggest additional items. The third section elicited demographic information from the participants, which included professional background (i.e., years engaged in work, educational background, professional title, and affiliation). In this section, the expert degree of authority also was measured. The authority coefficient (C~r~), in relation to the participants' technical ability to evaluate the items, was determined by two factors: the participants' familiarity with the items (C~s~) and the judgment criteria for the items (C~a~) \[[@CR41]\]. Familiarity with items was measured on a 5-point Likert Scale in the following order and score: unfamiliar (0), somewhat unfamiliar (0.2), somewhat familiar (0.5), very familiar (0.8), extremely familiar (1). The judgment criteria for the items encompassed parameters such as experience in asthma self-management, theoretical analysis of items, knowledge of the literature, and instinct. A scoring system was used to rate the experts' criterion for their judgments (see Table [3](#Tab3){ref-type="table"}) \[[@CR42]\], and the rating was done by the participants. Informed consent was obtained from each participant once they accepted the invitation to participate. Table 3Criterion for judgment and scoring systemJudgment CriterionThe Degree of Impact on Experts' JudgementLargeMediumSmallImpactImpactImpactExperience0.50.40.3Theoretical analysis0.30.20.1Knowledge of literature0.10.080.05Instinct0.10.070.05

### Round 2 of Delphi survey---determining the weight of each item through AHP {#Sec8}

The second round of the Delphi survey ended in January, 2018 with 24 experts participating. Of these, 20 participated in the first-round and four new experts were added. The five participants who dropped out after the first round did so because of vacations. The second-round questionnaires were based on the results of the first-round, according to both the agreement on each item and the suggestions of experts. Participants were required to (1) re-rate the importance of the items on the questionnaire regarding the apps and (2) provide additional edits, revisions, suggestions, comments, and/or questions. The three sections of the round two questionnaire followed the same format as the round one questionnaire. However, in the second-round questionnaire, expert participants were provided judgment criteria to evaluate the relative importance of 10 dimensions, using a series of pairwise comparisons, and the median of the score of each item was used to construct judgement matrices of the 10 dimensions by first author (see Fig. [2](#Fig2){ref-type="fig"}) \[[@CR43]\]. Meanwhile, the number of sub-dimension and items are large, affects the judgement of experts. So, in this study, the average score of importance of each item minus the average score of other items from the second Delphi round was used to extract the intensity of importance (formula 3), then construct judgment matrices, Table [4](#Tab4){ref-type="table"} exhibits standard of pairwise comparison values for sub-dimensions and items \[[@CR44]\]. According to formula 3 and standard of intensity of importance, we got the judgement matrices B sub-dimension of asthma knowledge (see Fig. [3](#Fig3){ref-type="fig"}). $$\documentclass[12pt]{minimal}
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The eigenvector of judgement matrix was calculated, and then the weight of each item was obtained.

### Round 3 of Delphi survey {#Sec9}

The third round of the Delphi survey ended in April, 2018. Eleven participants from the first round were invited and agreed to take part. Their ages ranging from 32 to 53 (mean = 41.00; SD = 6.55) in round three. Table [5](#Tab5){ref-type="table"} exhibits the demographic data and characteristics of the expert participants who took part in the three rounds of the Delphi survey. The round-three questionnaires featured the format as the round-one and round-two questionnaires. The expert participants were asked to re-rate the importance of the items on the questionnaire, using the same 5-point Likert scale. Table 5Demographic data and characteristics of the expert panelRound 1 (*N* = 25)\
N (%)Round 2 (*N* = 24)\
N (%)Round 3 (*N* = 11)\
N (%)Age (years)  \< 40 years old11 (44.0)11 (45.8)6 (54.5) 40--50 years old10 (40.0)9 (37.5)3 (27.3)  \> 50 years old4 (16.0)4 (16.7)2 (18.2)Work experience (years) 10 years or less12 (48.0)12 (50.0)7 (63.6) 10--20 years10 (40.0)9 (37.5)2 (18.2) More than 20 years3 (12.0)3 (12.5)2 (18.2)Education Bachelor's degree5 (20.0)5 (20.8)1 (9.1) Master's degree13 (52.0)10 (41.7)7 (63.6) PhD7 (28.0)9 (37.5)3 (27.3)Professional Title Intermediate title11 (44.0)8 (33.3)4 (36.4) Senior vice title10 (40.0)11 (45.8)5 (45.4) Senior title4 (16.0)5 (20.8)2 (18.2)Affiliation Educational institution6 (24.0)5 (20.8)5 (45.5) Clinical practice19 (76.0)19 (79.2)6 (54.5)

Participants remained anonymous to each other during the entire survey process, and they were required to complete the questionnaires within 3 weeks. Data collection was performed by the same member of the research team. All of the questionnaires and the data collection procedures were checked by the all members of the research team to assure credibility. The data was double-entered and checked for accuracy.

Data analysis {#Sec10}
-------------

Quantitative data were entered into Microsoft Excel 2010 and IBM SPSS 20.0 Statistics for Windows for analysis, and descriptive statistics were used. The rating for each item was analyzed and expressed as a mean value with standard deviation (SD). Following this, non-parametric statistics (e.g., chi-squared test of association) were used to determine the possibility of any response group bias. Coefficient of variation (CV) and Kendall's coefficient of concordance (Kendall's *W*) were used to test the dispersion of the participants' opinions. A *p* value of less than 0.05 was considered statistically significant.

Results {#Sec11}
=======

Survey results {#Sec12}
--------------

In round one of the Delphi survey, the authoritative coefficient for the expert participants ranged from 0.80 to 0.96, with an average authority coefficient of 0.89. The mean importance ratings for dimensions ranged from 3.28 to 4.88, and the coefficient of variation ranged from 0.07 to 0.37. The mean importance ratings for sub-dimensions ranged from 3.20 to 4.86, and the coefficient of variation ranged from 0.04 to 0.39. The mean importance ratings for items ranged from 3.44 to 4.92, and the coefficient of variation ranged from 0.06 to 0.32. In round two, the participants' degree of authority ranged from 0.65 to 1.00, with an average authority coefficient of 0.91. The mean importance ratings for dimensions ranged from 4.00 to 4.92, and the coefficient of variation ranged from 0.06 to 0.23. The mean importance ratings for sub-dimensions ranged from 4.00 to 4.88, and the coefficient of variation ranged from 0.07 to 0.26. The mean importance ratings for items ranged from 3.54 to 4.83, and the coefficient of variation ranged from 0.08 to 0.34. In round three, the participants' degree of authority ranged from 0.67 to 0.98, with an average authority coefficient of 0.90. The mean importance ratings for the dimensions ranged from 4.36 to 4.91, and the coefficient of variation ranged from 0.06 to 0.20. The mean importance ratings for the sub-dimensions ranged from 4.27 to 4.91, and the coefficient of variation ranged from 0.06 to 0.18. The mean importance ratings for the items ranged from 4.45 to 4.91, and the coefficient of variation ranged from 0.06 to 0.19. After modification of the items in the questionnaire, the coordination results in the third round were acceptable---the Kendall's *W* ranged from 0.654 to 0.693 (see Table [6](#Tab6){ref-type="table"}). Table 6The concordance degree of the expert's opinionsItemsKendall's *W*χ^2^*P*Round 1Dimensions0.440105.692\<  0.001Sub-Dimensions0.410226.335\<  0.001Items0.412859.754\<  0.001Round 2Dimensions0.569104.780\<  0.001Sub-Dimensions0.548239.506\<  0.001Items0.507758.071\<  0.001Round 3Dimensions0.69369.335\<  0.001Sub-Dimensions0.654150.503\<  0.001Items0.656413.448\<  0.001

Item modifications {#Sec13}
------------------

Table [7](#Tab7){ref-type="table"} illustrates the requirements for consensus for all items in rounds 1, 2 and 3. Criteria reaching consensus were retained while those not reaching consensus were removed. Table 7Requirements for consensus in rounds 1, 2 and 3CriterionRound 1Round 2Round 3Percentage important≥42%≥44%≥65%Mean importance rating≥4.09≥4.21≥4.53Coefficient of variation\<0.23\<0.20\<0.16

In round one of the Delphi survey, based on consensus criteria and team discussion, two dimensions were deleted, *reward and threat* was deleted because of its negative impact on patients, and *natural consequences* were deleted because of perceived duplication. Five of sub-dimensions (i.e., *social reward*, *threat*, *information about health consequences*, *salience of consequences*, and *regulation*) and 24 of items were deleted. An example for retaining items based on consensus criteria was shown in Table [8](#Tab8){ref-type="table"}. In addition, the three dimensions were changed, *improving the compliance* was reworded as *prompts*, *Asthma information* was changed to *asthma knowledge*, and *patient skills training* was reworded as *skills training for effective self-management* because of its inaccurate language. Seven of sub-dimensions (i.e., *prompts, the nature of asthma, management of comorbidities, peak flow meter usage, inhaler technique, identifying and avoiding risk factors, good life style*) and 42 of items were changed. Additionally, two new dimensions (i.e., *ease of use* and *usability*), eight new sub-dimensions (*warnings, accessibility, automation, unconstraint, user-friendly interface, security, usefulness of knowledge, rate of update*), and 15 new items were proposed by the participants to be added to the questionnaire after the first-round survey, which resulted in the inclusion of 10 dimensions, 25 sub-dimensions, and 73 items in the second-round questionnaire. Moreover, the wording of most items was revised based on the expert panel's comments and re-ordered the items concerning asthma self-management education and behavior change strategies. Table 8An example for retaining items based on the requirements for consensus in round oneDimensionMeanCVThe percentage importantDecisionAsthma knowledge4.800.08380%RemainingReward and threat3.280.37120%RemovedSocial support4.080.22940%Remaining after discussionCriterion≥4.09\<0.23≥42%

In round two, no new items were generated. Based on the criteria and team discussion, three of sub-dimensions (i.e., *behavior substitution*, *unconstraint*, and *security*) and 10 items were deleted. Three items were changed (*Information released by apps can help patients to make decision* was changed to *The app can be easily accessed and obtained information.*; *The app can help patients to improve the efficiency of self-management* was changed to *Information released by apps is to patients' needs and value; The app can help patients to know the recent knowledge* was changed to *The app is updated regularly and timely*) based on the suggestions of the expert participants. As a result, 10 dimensions, 23 sub-dimensions, and 63 items were generated for the second round of the Delphi survey. In addition, we added descriptions and/or examples for items in the questionnaire.

In round three, only one item (i.e., *the app allows users to re-set the goals based on patients' health data*) was deleted because difficult to be measured. As a result, the final version of asthma apps assessment framework comprised 10 dimensions, 23 sub-dimensions, and 62 items after three Delphi surveys. See Table [9](#Tab9){ref-type="table"}. Table 9Asthma apps assessment framework and weight value of each item after three-round Delphi surveyDimensionsWeightSub-DimensionsWeightItemsCriteria/ExampleWeightOverall WeightThe following knowledge is included in the apps (i.e., presented in words, pictures, video, etc.): Asthma knowledge0.105Basic fact about asthma0.182Definition of asthmaAsthma is a chronic respiratory disease, together with airway hyperresponsiveness and airway inflammation0.0860.0016Causes of asthmaAsthma is caused by a combination of endogenous (genetic) and external (environment) causes0.1230.0024Respiratory symptoms of asthmaRepeated episodes of wheeze, shortness of breath, chest tightness and cough0.1770.0034Prognosis of asthmaAsthma cannot be cured, but can be effectively controlled through effective management0.2530.0048Early treatmentEarly controller treatment of asthma is critical to achieving optimal outcomes0.3610.0069Asthma medications0.439Categories of asthma medicationsAsthma medications include controller medications and reliever medications0.1380.0063Roles and usage of controller medicationsController medications can be used to reduce airway inflammation, control symptoms, and reduce future risks, which must be used regularly0.2400.0110Roles and usage of reliever medicationsReliever medications can be used to relief breakthrough symptoms, which must be used as needed0.1820.0084Side-effects of asthma medicationsLocal side effects of ICS include oral thrush and dysphonia; osteoporosis, hypertension, and diabetes, etc. in high dose steroids; tachycardia and tremor in ß~2~-agoinsts0.0960.0044Carrying reliever medicationsPatients need to carry asthma reliever medications (such as Ventolin solution) with them in case of emergency0.3440.0158Management of asthma exacerbations0.241Early signs and symptoms of worsening asthmaThe app describes early signs and symptoms of worsening asthma (sneezing, runny nose, dry cough, shortness of breath, and chest tightness, etc.)0.1380.0035Symptoms of asthma exacerbationsThe app describes symptoms of asthma exacerbations (a progressive increase in symptoms of shortness of breath, cough, wheezing or chest tightness)0.1950.0049Management of asthma exacerbationsFor example, patients were removed from the allergen environment, inhale ß~2~ agonist, and went to see the doctor in time0.3910.0098Management after asthma exacerbationsSeek the cause of acute attack actively, check medication compliance, and adjust treatment plan0.2760.0070Asthma with comorbidities and triggers0.138Comorbidities of asthmaThe app describes comorbidities of asthma, such as, rhinitis, sinusitis, and symptomatic gastroesophageal reflux disease, etc.0.2490.0036Management of comorbiditiesThe app provides details of treatment of rhinitis, sinusitis, and symptomatic gastroesophageal reflux disease, and psychological intervention, etc.0.1570.0023Triggers of asthmaThe app describes triggers of asthma, such as, occupational factors, environmental factors, weather changes, drug and sports0.5940.0086 Skills training for effective self-management0.203Peak flow meter use and monitoring0.667The purpose of using peak flow meterA peak flow meter is used for monitoring lung function changes in patients0.1950.0264Operational criteria for peak flow meterTake a deep breath, seal your mouth tightly around the mouthpiece and then blow as hard and as fast as you soon. Check the number, re-set the pointer to zero, and repeat two more times0.3910.0527The same peak flow meterThe patient should use the same peak flow meter each time0.2760.0373The best time to use peak flow meterPEF is measured in the morning, and then in the evening (after 10-12 h of the first time)0.1380.0186Inhaler devices use0.333Common inhaler devicesThe app describes common inhaler devices, such as pressurized metered dose inhalers (pMDI), pMDI +spacer and dry power inhalers (DPIs)0.1400.0094The importance of correct inhaler techniqueCorrect inhaler technique can enhance the medication into lung, reduce asthma attack, and obtain the best clinical effect0.5280.0356Operational criteria for different inhaler devicesFor example, usage of Diskus is that remove mouthpiece cover, position inhaler mouthpiece in mouth and seal lips, inward breath steady and deeply, remove inhaler, hold breath for a few seconds, and rinse mouth0.3320.0225 Non- pharmacological strategies0.094Measures to treat asthma triggers0.667Identifying risk factors that make asthma worseThe app describes factors that make asthma worse, such as allergens exposure, physical and chemical irritants, psychosocial factors, etc.0.1600.0100Avoidance of environmental smoke exposureThe app provides advice about avoidance of active smoking and passive smoking0.1060.0066Avoidance of occupation exposuresThe app provides advice about avoidance of plant dust, animal dust, etc.0.2550.0159Avoidance of medications that may make asthma worseThe app provides advice about avoidance of aspirin, NSAIDs, and ß-blockers, etc.0.2550.0159Avoidance of allergen exposureThe app provides advice about avoidance of domestic mites, furred animals, fungi, and pollen, etc.0.1600.0100Avoidance of indoor and outdoor air pollutionThe app provides advice about avoidance of domestic coal burning, cooking, and traffic pollution, etc.0.0640.0040Lifestyles0.333Avoidance of emotional stressThe app provides advice about relieving emotional stress and encouraging breathing exercises, etc.0.6670.0209Regular moderate physical activityPatients should exercise regularly and given appropriate exercise advice0.3330.0104The following behavioral change strategies are employed in apps: Goals and planning0.068Goal setting (outcome/behavior)0.667Allow users to set behavior goals or provide behavior goalsThe app allows users to record symptoms and PEF values daily, and assess asthma control level periodically, etc.0.6670.0300Allows users to set outcome goals or provide outcome goalsThe app allows users to set the goals of asthma control0.3330.0150Action plans0.333Explain the purpose of an asthma action planAn asthma action plan helps patients to identify early symptoms of asthma attacks and respond appropriately to improve asthma control0.5000.0113Allow making individualized asthma action plan, and updated in timeThe app allows doctors to program asthma action plan directly into their phone or users type in manually0.5000.0113 Feedback and monitoring0.084Feedback0.250Provide result feedback information based on patients' health dataThe app can provide advice based on changing PEF, symptoms or ACT scores0.1850.0039Provide professional feedback information based on patients' inhaler techniqueThe app allows users to upload the patients' inhaler technique video through user-end, and then clinicians check inhaler technique in order to identify problematic steps0.2450.0051Provide feedback information based on patients' changing asthma statusThe app can provide feedback about severity of asthma based on symptoms or PEF, etc.0.3230.0068Allow storing and summarizing patients' recent health data, and generating summary visualization automaticallyThe app allows storing patients' data, such as symptoms, PEF or medicine use0.1410.0030Allow connecting medical devices or wearables to upload data and provide feedback information to patientsFor example, after the sensor collecting the patients' vital signs, the app can send the data to end-users and judge whether the patients' health is in the normal range0.1060.0022Self-monitoring of behavior0.500Provide a diary to record PEF readings and predicted PEFR will be calculated automaticallyThe app allows users to type in manually or supports pair to the patients' Bluetooth device automatically for data exchange0.1950.0082Provide a diary to record patients' symptoms.The app provides a diary to record details about wheezing/shortness of breath/sleep, etc.0.3910.0164Provide a diary to record medication.The app provides a diary to record details about medication use, such as categories and frequency, etc.0.2760.0116Provide a diary to record return visit.The app provides a diary to record details about return visit, such as frequency and results, etc.0.1380.0058Self-monitoring of outcomes of behavior0.250Provide a diary to record lung function test.The app provides a diary to record details about lung function test, such as FEV~1~, FVC, etc.0.0065Provide a diary to record worsening asthma-related events.The app provides a diary to record details about worsening asthma-related events, such as attack symptoms, duration of symptoms, and complications, etc.0.1960.0041Provide asthma assessment toolsThe app provides asthma assessment tools to assess patient progress, such as Asthma Control Test (ACT)0.4930.0104 Shaping knowledge0.105Demonstration of behavior1.000Provide video tutorials or animations of peak flow meter useThe app provides video tutorials or animations to display instructions of peak flow meter for patients0.5000.0524Provide video tutorials or animations of inhaler devices useThe app provides video tutorials or animations to display instructions of inhaler device for patients0.5000.0524 Social support0.049Practical support0.667Allow establishing a cooperative relationship between doctors and patients, and providing patient-doctor communication platform or interactive consultation serviceFor example, the app offers online consulting service0.1000.0324Emotional support0.333Provide functions of interactive communication among patientsFor example, the app provides functions of sharing information and comment, etc.0.1000.0162 Prompts0.084Reminder0.333Allow users to set reminders for asthma tests.The app provides details of asthma tests reminder0.1390.0039Allow users to set medication reminderThe app provides details of medication reminder, such as medication name and dosage, etc.0.3930.0110Allow users to set reminders for return visitThe app can send information regularly to remind return visit0.2340.0066Provide reminders for checking inhalersThe app provides reminders for checking the date and medications dosage of inhalers0.2340.0066Warnings0.667Provide alert based on patients' changing health dataThe app can send warning information automatically when there is abnormal data1.0000.0561The following design principles are implemented in the apps: Ease of use0.105Accessibility0.429The app can be easily accessed and obtained informationThe app and its contents are accessible to all users (including all kinds of users with access barriers, such as visual impairment, hearing impairment, etc.)1.0000.0449Automation0.429The app can retrieve patients' data automaticallyThe app can connect to health apparatuses to improve efficiency of data collection1.0000.0449User-friendly interface0.142All components/screens, menu labels/icons of apps are clear, intuitive, and able to use immediatelyInterface design (including menu, background, colors, fonts, etc.) is scientific and reasonable. The operation steps are simple and can be operated according to window prompts without user guide. Navigation is logical and intuitive, and internal and external links are valid1.0000.0150 Usability0.105Usefulness of knowledge0.250Information released by apps is for patient's needs and valueInformation contained within apps is accurate and comprehensive, with high utilization rate1.0000.0262Rate of update0.750The app is updated regularly and timelyThe app (including its contents, functions and technology) is updated regularly and timely1.0000.0786

Calculating the weight of items through AHP {#Sec14}
-------------------------------------------

In round two, the weights of the dimensions were 0.105, 0.203, 0.094, 0.068, 0.084, 0.105, 0.049, 0.084, 0.105, 0.105, respectively, with a CR of 0.037. The overall weights of the sub-dimensions ranged from 0.015 to 0.135, with CR values from 0 to 0.062. Moreover, the overall weights of the items ranged from 0.002 to 0.079, with CR values ranging from 0 to 0.046.

Discussion {#Sec15}
==========

Much of the literature concerning the evaluation of mHealth apps has merely addressed the technical aspects of apps \[[@CR45]--[@CR49]\]. The purpose of this study was to develop a framework to assess and improve the quality of asthma smartphone apps for use on smartphones. The three-round Delphi survey process produced consensus on the items comprising a framework for assessing the quality of asthma apps, from the perspective of both asthma self-management education and behavior change strategies. The framework features 10 dimensions and corresponding items, which reflect the material content of asthma apps currently available for download on smartphones. This framework is an important first step in using asthma apps as part of the set of strategies available to healthcare providers to improve quality of life (QOL) among asthmatics.

Through the three-round Delphi survey process, the number of items to be included in the assessment framework was reduced from 87 to 62, by merging overlapping items and deleting items that would be difficult to operationalize and measure, based on feedback. Asthma self-management should address asthma knowledge, skills training for effective self-management, non-pharmacological interventions, goals and planning, feedback and monitoring, shaping knowledge, social support, and prompts (i.e., brief messages that encourage the user to engage in particular behaviors).

Among the dimensions, *skills training for effective self-management* had the highest weight (0.203), followed by *asthma knowledge* (0.105), *shaping knowledge* (0.105), *ease of use* (0.105) and *usability* (0.105). Therefore, *skills training for effective self-management* is the most important factor in asthma self-management, from the perspective of participating experts and consistent with the literature \[[@CR50], [@CR51]\]. Moreover, reports of web-based interventions have shown that interventions involving more behavior change techniques are indeed effective \[[@CR52]\].

The framework can be used to create an evaluation instrument which could then be tried out and evaluated itself for validity and reliability.

Limitations {#Sec16}
-----------

This study identified a framework and a needed next step would be to derive and validate an actual instrument. The framework only reflects the judgement of the participants' choosen and that another group, perhaps in another country or composed of more multidisciplinary experts, might produce a different framework. The fact that participants were all asthma experts explains why the framework's content is so heavily focused on the disease and its treatment and why an essential item for all health related apps like privacy and security is missing. Cost, software reliability, and whether patients understand the information apps present might be concerns of those in the telemedicine field. While ease of use may touch upon this, another telemedicine concern flowing from understandability is how much knowledge apps assume patients have.

In addition, the whole research was conducted in China (a middle-income Asian nation). The sample size was small, leading to many semi-qualitative results. Also, the path for future research in applying the framework in culturally diverging regions of lower (e.g. sub-Saharan Africa) and/or higher (e.g. Europe) exists. The framework designed surveyed providers (and not patients) about what they think is good for patients. Future research might include an analogous methodology used with severely affected ("expert") asthma patients, etc. Still, the current framework provides guidance for assessing asthma content and behavioral strategies in existing apps on developing new one.

Conclusion {#Sec17}
==========

This study involved 29 experts who were active in respiratory disease field for more than 5 years. The assessment framework created can be used to develop evaluation instruments for asthma apps that can be used by health researchers and healthcare professionals wishing to incorporate them in their treatment plans and to guide the development of quality asthma apps supporting patient self-management. Among them, portion of behavior change strategies of the framework can be used in evaluation of HIT apps for other chronic and common disorders.
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